0001375852-19-000011.txt : 20191210
0001375852-19-000011.hdr.sgml : 20191210
20191210172925
ACCESSION NUMBER: 0001375852-19-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191209
FILED AS OF DATE: 20191210
DATE AS OF CHANGE: 20191210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Scott E
CENTRAL INDEX KEY: 0001375852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 191278491
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-12-09
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001375852
Lamb Scott E
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer,
Common Stock
2019-12-09
4
X
0
9185
58.79
A
22494
D
Common Stock
2019-12-09
4
S
0
9133
180.5705
D
13361
D
Common Stock
2019-12-09
4
S
0
41
181.0884
D
13320
D
Common Stock
2019-12-09
4
S
0
11
184.0
D
13309
D
Common Stock
2019-12-10
4
X
0
20815
58.79
A
34124
D
Common Stock
2019-12-10
4
S
0
4738
177.2213
D
29386
D
Common Stock
2019-12-10
4
S
0
15904
178.1401
D
13482
D
Common Stock
2019-12-10
4
S
0
173
179.1858
D
13309
D
Non-Qualified Stock Option (right to buy)
58.79
2019-12-09
4
X
0
9185
58.79
D
2024-02-24
Common Stock
9185
65815
D
Non-Qualified Stock Option (right to buy)
58.79
2019-12-10
4
X
0
20815
58.79
D
2024-02-24
Common Stock
20815
45000
D
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.98, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $181.00 to $181.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $177.00 to $177.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $178.00 to $178.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
he price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $179.18 to $179.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
By: Paula Darbyshire Attorney-In-Fact For: Scott E. Lamb
2019-12-10